PDB Short entry for 5E1S HEADER TRANSFERASE 30-SEP-15 5E1S TITLE THE CRYSTAL STRUCTURE OF INSR TYROSINE KINASE IN COMPLEX WITH THE TITLE 2 INHIBITOR BI 885578 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IR; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INSR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, INSR, IGF-1R, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.KESSLER,S.ZAHN,M.SANDERSON,B.WOLKERSTORFER REVDAT 3 10-JAN-24 5E1S 1 REMARK REVDAT 2 16-DEC-15 5E1S 1 JRNL REVDAT 1 14-OCT-15 5E1S 0 JRNL AUTH M.P.SANDERSON,J.APGAR,P.GARIN-CHESA,M.H.HOFMANN,D.KESSLER, JRNL AUTH 2 J.QUANT,A.SAVCHENKO,O.SCHAAF,M.TREU,H.TYE,S.K.ZAHN, JRNL AUTH 3 A.ZOEPHEL,E.HAAKSMA,G.R.ADOLF,N.KRAUT JRNL TITL BI 885578, A NOVEL IGF1R/INSR TYROSINE KINASE INHIBITOR WITH JRNL TITL 2 PHARMACOKINETIC PROPERTIES THAT DISSOCIATE ANTITUMOR JRNL TITL 3 EFFICACY AND PERTURBATION OF GLUCOSE HOMEOSTASIS. JRNL REF MOL.CANCER THER. V. 14 2762 2015 JRNL REFN ESSN 1538-8514 JRNL PMID 26438154 JRNL DOI 10.1158/1535-7163.MCT-15-0539 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 16877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 851 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.38 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2907 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2289 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2747 REMARK 3 BIN R VALUE (WORKING SET) : 0.2276 REMARK 3 BIN FREE R VALUE : 0.2507 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2259 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.38030 REMARK 3 B22 (A**2) : -6.58100 REMARK 3 B33 (A**2) : -0.79930 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.331 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.302 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.282 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.225 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2366 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3204 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 838 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 61 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 336 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2366 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 289 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 1 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2743 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 13.7278 14.5020 17.8066 REMARK 3 T TENSOR REMARK 3 T11: -0.1814 T22: -0.1119 REMARK 3 T33: -0.1278 T12: -0.0058 REMARK 3 T13: 0.0154 T23: -0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.9788 L22: 1.8910 REMARK 3 L33: 2.1436 L12: -1.0229 REMARK 3 L13: -0.1155 L23: 0.2039 REMARK 3 S TENSOR REMARK 3 S11: -0.0586 S12: -0.0461 S13: 0.1267 REMARK 3 S21: 0.0671 S22: 0.0645 S23: -0.1357 REMARK 3 S31: -0.0266 S32: -0.1118 S33: -0.0059 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5E1S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213312. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16922 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.264 REMARK 200 RESOLUTION RANGE LOW (A) : 37.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : 0.08500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.63600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1IRK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 8000, 0.1M TRIS PH 7.3, 50MM REMARK 280 NACL, 5 MM DTT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.27500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.92500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.18500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.92500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.27500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.18500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 976 REMARK 465 SER A 977 REMARK 465 VAL A 978 REMARK 465 PHE A 979 REMARK 465 PRO A 980 REMARK 465 SER A 981 REMARK 465 SER A 982 REMARK 465 THR A 1154 REMARK 465 ARG A 1155 REMARK 465 ASP A 1156 REMARK 465 ILE A 1157 REMARK 465 TYR A 1158 REMARK 465 GLU A 1159 REMARK 465 THR A 1160 REMARK 465 ASP A 1161 REMARK 465 TYR A 1162 REMARK 465 TYR A 1163 REMARK 465 ARG A 1164 REMARK 465 LYS A 1165 REMARK 465 GLY A 1166 REMARK 465 GLY A 1167 REMARK 465 LYS A 1168 REMARK 465 GLY A 1169 REMARK 465 LEU A 1170 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 VAL A 983 REMARK 475 TYR A 984 REMARK 475 VAL A 985 REMARK 475 PRO A 986 REMARK 475 MET A 1153 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 994 CD OE1 OE2 REMARK 480 LYS A 995 CG CD CE NZ REMARK 480 ARG A 1016 NE CZ NH1 NH2 REMARK 480 GLU A 1024 CG CD OE1 OE2 REMARK 480 GLU A 1034 CG CD OE1 OE2 REMARK 480 ARG A 1041 NE CZ NH1 NH2 REMARK 480 LYS A 1052 CD CE NZ REMARK 480 LYS A 1068 CG CD CE NZ REMARK 480 GLN A 1070 CG CD OE1 NE2 REMARK 480 LYS A 1085 CE NZ REMARK 480 GLU A 1094 CG CD OE1 OE2 REMARK 480 GLU A 1096 CG CD OE1 OE2 REMARK 480 ARG A 1101 CG CD NE CZ NH1 NH2 REMARK 480 GLN A 1211 CG CD OE1 NE2 REMARK 480 LYS A 1220 CD CE NZ REMARK 480 ARG A 1243 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 987 -158.46 -132.74 REMARK 500 ARG A1131 -7.85 70.18 REMARK 500 ASN A1132 29.20 -141.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5JA A 1301 DBREF 5E1S A 978 1283 UNP P06213 INSR_HUMAN 1005 1310 SEQADV 5E1S GLY A 976 UNP P06213 EXPRESSION TAG SEQADV 5E1S SER A 977 UNP P06213 EXPRESSION TAG SEQADV 5E1S SER A 981 UNP P06213 CYS 1008 CONFLICT SEQADV 5E1S ASN A 1132 UNP P06213 ASP 1159 CONFLICT SEQRES 1 A 308 GLY SER VAL PHE PRO SER SER VAL TYR VAL PRO ASP GLU SEQRES 2 A 308 TRP GLU VAL SER ARG GLU LYS ILE THR LEU LEU ARG GLU SEQRES 3 A 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY ASN SEQRES 4 A 308 ALA ARG ASP ILE ILE LYS GLY GLU ALA GLU THR ARG VAL SEQRES 5 A 308 ALA VAL LYS THR VAL ASN GLU SER ALA SER LEU ARG GLU SEQRES 6 A 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLY SEQRES 7 A 308 PHE THR CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 A 308 SER LYS GLY GLN PRO THR LEU VAL VAL MET GLU LEU MET SEQRES 9 A 308 ALA HIS GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 A 308 PRO GLU ALA GLU ASN ASN PRO GLY ARG PRO PRO PRO THR SEQRES 11 A 308 LEU GLN GLU MET ILE GLN MET ALA ALA GLU ILE ALA ASP SEQRES 12 A 308 GLY MET ALA TYR LEU ASN ALA LYS LYS PHE VAL HIS ARG SEQRES 13 A 308 ASN LEU ALA ALA ARG ASN CYS MET VAL ALA HIS ASP PHE SEQRES 14 A 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE SEQRES 15 A 308 TYR GLU THR ASP TYR TYR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 A 308 LEU PRO VAL ARG TRP MET ALA PRO GLU SER LEU LYS ASP SEQRES 17 A 308 GLY VAL PHE THR THR SER SER ASP MET TRP SER PHE GLY SEQRES 18 A 308 VAL VAL LEU TRP GLU ILE THR SER LEU ALA GLU GLN PRO SEQRES 19 A 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU LYS PHE VAL SEQRES 20 A 308 MET ASP GLY GLY TYR LEU ASP GLN PRO ASP ASN CYS PRO SEQRES 21 A 308 GLU ARG VAL THR ASP LEU MET ARG MET CYS TRP GLN PHE SEQRES 22 A 308 ASN PRO LYS MET ARG PRO THR PHE LEU GLU ILE VAL ASN SEQRES 23 A 308 LEU LEU LYS ASP ASP LEU HIS PRO SER PHE PRO GLU VAL SEQRES 24 A 308 SER PHE PHE HIS SER GLU GLU ASN LYS HET 5JA A1301 39 HETNAM 5JA (5R)-N-(1-{2-[4-(2-METHOXYETHYL)PIPERAZIN-1-YL]ETHYL}- HETNAM 2 5JA 1H-PYRAZOL-3-YL)-5,8-DIMETHYL-9-PHENYL-6,8-DIHYDRO-5H- HETNAM 3 5JA PYRAZOLO[3,4-H]QUINAZOLIN-2-AMINE FORMUL 2 5JA C29 H37 N9 O FORMUL 3 HOH *137(H2 O) HELIX 1 AA1 SER A 992 GLU A 994 5 3 HELIX 2 AA2 SER A 1037 LYS A 1052 1 16 HELIX 3 AA3 LEU A 1084 LEU A 1091 1 8 HELIX 4 AA4 THR A 1105 LYS A 1126 1 22 HELIX 5 AA5 ALA A 1134 ARG A 1136 5 3 HELIX 6 AA6 PRO A 1172 MET A 1176 5 5 HELIX 7 AA7 ALA A 1177 GLY A 1184 1 8 HELIX 8 AA8 THR A 1187 LEU A 1205 1 19 HELIX 9 AA9 SER A 1214 ASP A 1224 1 11 HELIX 10 AB1 PRO A 1235 TRP A 1246 1 12 HELIX 11 AB2 ASN A 1249 ARG A 1253 5 5 HELIX 12 AB3 THR A 1255 LYS A 1264 1 10 HELIX 13 AB4 ASP A 1265 LEU A 1267 5 3 HELIX 14 AB5 SER A 1270 SER A 1275 1 6 SHEET 1 AA1 5 ILE A 996 GLN A1004 0 SHEET 2 AA1 5 MET A1009 ARG A1016 -1 O GLU A1012 N ARG A1000 SHEET 3 AA1 5 GLU A1024 THR A1031 -1 O VAL A1029 N TYR A1011 SHEET 4 AA1 5 LEU A1073 GLU A1077 -1 O VAL A1074 N LYS A1030 SHEET 5 AA1 5 LEU A1062 VAL A1066 -1 N LEU A1063 O VAL A1075 SHEET 1 AA2 3 GLY A1082 ASP A1083 0 SHEET 2 AA2 3 CYS A1138 VAL A1140 -1 O VAL A1140 N GLY A1082 SHEET 3 AA2 3 VAL A1146 ILE A1148 -1 O LYS A1147 N MET A1139 CISPEP 1 GLN A 1070 PRO A 1071 0 0.34 SITE 1 AC1 14 LEU A1002 GLY A1003 GLN A1004 VAL A1010 SITE 2 AC1 14 ALA A1028 GLU A1077 LEU A1078 MET A1079 SITE 3 AC1 14 ALA A1080 GLY A1082 ASN A1097 MET A1139 SITE 4 AC1 14 ASP A1150 HOH A1484 CRYST1 56.550 70.370 87.850 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017683 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014211 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011383 0.00000